RASSF1A promoter methylation and Kras2 mutations in non small cell lung cancer

Keyphrases

• Non-small Cell Lung Cancer (NSCLC) 100%
• Large Cell Carcinoma 100%
• Promoter Methylation 100%
• RASSF1A 100%
• Adenocarcinoma 71%
• Squamous Cell Carcinoma (SqCC) 57%
• Promoter Region 14%
• Adenocarcinoma Cells 14%
• CpG Island Methylation 14%
• Mutational Analysis 14%
• Methylation Status 14%
• Human Lung Adenocarcinoma Cells 14%
• Codon 12 14%
• Mutation Data 14%
• RASSF1A Methylation 14%
• Codon 13 14%

Medicine and Dentistry

• Non Small Cell Lung Cancer 100%
• Promoter Region 100%
• Methylation 100%
• Large Cell Carcinoma 100%
• Adenocarcinoma 85%
• Squamous Cell Carcinoma 57%
• Codon 14%
• Lung Adenocarcinoma 14%
• CpG Island 14%
• Non-Small Cell Lung Cancer 14%
• Mutational Analysis 14%

Biochemistry, Genetics and Molecular Biology

• Promoter Region 100%
• Methylation 100%
• Codon 14%
• CpG Island 14%